InvestorsHub Logo
Followers 740
Posts 61453
Boards Moderated 10
Alias Born 10/05/2009

Re: lumpy9200 post# 16620

Tuesday, 08/04/2020 10:05:50 AM

Tuesday, August 04, 2020 10:05:50 AM

Post# of 20000
A couple of notes on NDTP and the history:

1) The Private Biotech R/M here was started 7 years ago, not as Milv or as NDTP, but as CCA, LLC, (The firm R/M here to form NDTP Biotech birth) and has had JV joint ownership of the BBB Blood Brain Barrier crossing Nano-Liposome tech all that time with UPennMed, the top brain Trauma research University in the nation, and has not been Public during that time.

That means the super wealthy founders and MD's and Professors and UPennMed and NIH have funded the development and testing of this cutting edge, passed the barrier, technology as a Private company all this time.

How many Biotechs do that????

Zero???

I thought Google, Apple and Amazon were all too good be true as well.

All they need is one Gatorade drink line replacement with PepsiCo that enables TBI-Brain damage repair on the spot during an NFL game and this goes to a Billion dollar market cap with 290,000 share float.

All it needs is BBB-crossing vehicle they can license to a Novartis Biotech for a billion dollars (upfront and long term license fees) as Novartis pays for FDA trials using already FDA approved drugs packaged in the NDTP BBB-Crossing Liposomes to be a Billion dollar stock with one PR license agreement.

Get both this year and hit $300/share, Billion dollar market cap becomes an underestimate.

I am not the only one that thinks this is all highly probably based on what we know.

Can shit happen? Yes, #COVID19 happened and delayed the audit(s) and a TA goof with DTC happened, and the TA goof got fixed.

One thing I am sure of, CCA, LLC would not have completed all the last steps getting us to right here and right now, and the Custodian would not have sold/transferred the shell to Hovis and team/CCA, LLC owners, if they had not completed the 2019 audit and had a clean shell ready to turn the Larry Kubin lights on to go public.

Only Hold up now IMHO, is they may need 1 to 2, 10-Qs, and may need them audited, or may need new 10-Ks using March 31st of June 30th as year ends to meet the SEC S-1/1-A filling requirements to re-register, and go public completing the R/M. Not My field of expertise, but they doe 1-2 years of 1-Ks, can they just add 1 or 2, 10-Qs now???Or do they need a fresh last minute audit?

Either way I can wait a little longer to see my retirement plan bloom here.

Key DD is here:

https://ccabiotech.blogspot.com/p/members.html (The folks that built this biotech, all mega millionaires and top of the field nano tech inventors/Professors)

https://ccabiotech.blogspot.com/p/patent.html

https://ccabiotech.blogspot.com

https://ccabiotech.blogspot.com/home

This is a look at what I 100% sure is earlier R&D that this company was behind, based on 2016 SEC Filings.

http://grantome.com/grant/NIH/R01-NS069629-05
Dr Cohen Grants TBI Huge find!!!

https://www.researchgate.net/publication/322275261_Dietary_therapy_restores_glutamatergic_input_to_orexinhypocretin_neurons_after_traumatic_brain_injury_in_mice








All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.